Allergic Rhinitis Affects 40% of Children Worldwide and Prevalence Is Increasing – PR Web (press release)

Allergic Rhinitis Affects 40% of Children Worldwide and Prevalence Is Increasing
PR Web (press release)
Allergic rhinitis is a complex disease involving several associated disorders and is a risk factor for asthma, requiring treatment of multiple conditions. It affects 10% to 30% of adults and 40% of children worldwide, estimated at 400 million people by

and more »

View full post on asthma – Google News

Treatment of allergic asthma: Modulation of Th2 cells and their responses – 7thSpace Interactive (press release)

Treatment of allergic asthma: Modulation of Th2 cells and their responses
7thSpace Interactive (press release)
Atopic asthma is a chronic inflammatory pulmonary disease characterised by recurrent episodes of wheezy, laboured breathing with an underlying Th2 cell-mediated inflammatory response in the airways. It is currently treated and, more or less,

View full post on asthma – Google News

Allergic asthma on the breath: Metabolomics brings diagnosis a step closer – separationsNOW.com

Allergic asthma on the breath: Metabolomics brings diagnosis a step closer
separationsNOW.com
Allergic asthma, a sub-type of asthma, is a growing health problem affecting all age groups. The symptoms do not differ between the allergic and non-allergic condition, although the causes do. The allergens responsible are encountered commonly everyday

View full post on asthma – Google News

Research and Markets: the Asthma, COPD & Allergic Rhinitis Market Outlook to … – Business Wire (press release)

Research and Markets: the Asthma, COPD & Allergic Rhinitis Market Outlook to
Business Wire (press release)
The global respiratory market was valued at $44.0bn in sales in 2010 with asthma/COPD drugs being the key revenue drivers of the therapeutic segment. Of respiratory indications, asthma represents the main area of R&D interest for pharmaceutical

and more »

View full post on asthma – Google News

Reportlinker Adds The Asthma, COPD & Allergic Rhinitis Market Outlook to 2016 – Centre Daily Times

Reportlinker Adds The Asthma, COPD & Allergic Rhinitis Market Outlook to 2016
Centre Daily Times
The global respiratory market was valued at $44.0bn in sales in 2010 with asthma/COPD drugs being the key revenue drivers of the therapeutic segment. Of respiratory indications, asthma represents the main area of R&D interest for pharmaceutical

and more »

View full post on asthma – Google News

Reportlinker Adds The Asthma, COPD & Allergic Rhinitis Market Outlook to 2016 – SYS-CON Media (press release)

Reportlinker Adds The Asthma, COPD & Allergic Rhinitis Market Outlook to 2016
SYS-CON Media (press release)
The global respiratory market was valued at $44.0bn in sales in 2010 with asthma/COPD drugs being the key revenue drivers of the therapeutic segment. Of respiratory indications, asthma represents the main area of R&D interest for pharmaceutical

and more »

View full post on asthma – Google News

Omalizumab effective in treating inadequately controlled allergic asthma – BCM News

Omalizumab effective in treating inadequately controlled allergic asthma
BCM News
HOUSTON — (May 5, 2011) — Patients with severe allergic asthma that is inadequately controlled with the standard of care had improved symptoms and decreased flare-ups with injections of an antibody drug called omalizumab, according to experts at
Adding Omalizumab May Improve Uncontrolled AsthmaDoctors Lounge

all 3 news articles »

View full post on asthma – Google News

Pfizer returns allergic asthma drug to Rigel – FierceBiotech

Pfizer returns allergic asthma drug to Rigel
FierceBiotech
Pfizer's decision to ends its allergy and respiratory R&D work has prompted the company return rights to the R343 program for allergic asthma to Rigel Pharmaceuticals. The drug has shown promise in Phase I trials and Rigel plans to begin designing a
Rigel says Pfizer returns asthma therapy rightsReuters
Rigel Assumes Development Responsibility for Inhaled Asthma TherapyPR Newswire (press release)
Pfizer Hands Back Rigel DrugXconomy

all 16 news articles »

View full post on asthma – Google News

Asthma and related allergic diseases – Khaleej Times


Wilkes Barre Times-Leader

Asthma and related allergic diseases
Khaleej Times
DUBAI – Asthma and related allergic diseases constitute a growing health problem – and today, they are considered 'Epidemics of the 21st Century', affecting 10 to 50% of populations in all countries around the world. In the Middle East,
Control for Many Severe Asthmatics Still IllusivePR Newswire (press release)
Science Center to host free asthma screeningSTLtoday.com
Healthy Gardening Dos and Don'tsNBC Washington
American Council on Science and Health –Cosmos –About – News & Issues
all 24 news articles »

View full post on asthma – Google News